The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
New Applications of Heparin and Other Glycosaminoglycans
Open accessAbstract
Heparin, the widely used pharmaceutical anticoagulant, has been in clinical use for well over half a century. Its introduction reduced clotting risks substantially and subsequent developments, including the introduction of low-molecular-weight heparin, made possible many major surgical interventions that today make heparin an indispensable drug. There has been a recent burgeoning of interest in heparin and related glycosaminoglycan (GAG) polysaccharides, such as chondroitin sulfates, heparan sulfate, and hyaluronate, as potential agents in various applications. This ability arises mainly from the ability of GAGs to interact with, and alter the activity of, a wide range of proteins. Here, we review new developments (since 2010) in the application of heparin and related GAGs across diverse fields ranging from thrombosis and neurodegenerative disorders to microbiology and biotechnology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Sapsford, K. E., Algar, W. R., Berti, L., Gemmill, K. B., Casey, B. J., Oh, E., Stewart, M. H., & Medintz, I. L. (2013) · Chemical Reviews · doi:10.1021/cr300143v · Cited by 1,423
Borsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061615598 · Cited by 714
Glycosaminoglycans: key players in cancer cell biology and treatment
Afratis, N., Gialeli, C., Nikitovic, D., Tsegenidis, T., Karousou, E., Theocharis, A. D., Pavão, M. S., Tzanakakis, G. N., & Karamanos, N. K. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08529.x · Cited by 554
Schulze, A., Gripon, P., & Urban, S. (2007) · Hepatology · doi:10.1002/hep.21896 · Cited by 445
Molecular Basis for the Relationship Between Thrombosis and Cancer
Rickles, F. R., & Falanga, A. (2001) · Thrombosis Research · doi:10.1016/s0049-3848(01)00285-7 · Cited by 329
Domain Structure of Heparan Sulfates from Bovine Organs
Maccarana, M., Sakura, Y., Tawada, A., Yoshida, K., & Lindahl, U. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17804 · Cited by 284
Nelson, A., Berkestedt, I., Schmidtchen, A., Ljunggren, L., & Bodelsson, M. (2008) · Shock · doi:10.1097/shk.0b013e3181777da3 · Cited by 271
Broad-spectrum antivirals against viral fusion
Vigant, F., Santos, N. C., & Lee, B. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3475 · Cited by 266
Wang, D., Ichiyama, R. M., Zhao, R., Andrews, M. R., & Fawcett, J. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0983-11.2011 · Cited by 205
Research works printed but not linked: 2
- Gibbon, 1939, The maintenance of life during experimental occlusion of the pulmonary artery followed by survival, Surg Gynecol Obs., 69, 602
- Harenberg, J., and Casu, B. (2012). Nonanticoagulant Actions of Glycosaminoglycans, Springer US.
Cited by
De Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20
“The anticoagulant activity is mediated by the activating antithrombin III (a serine protease inhibitor), which, in turn, blocks thrombin, thereby inhibiting blood coagulation factors, Xa and IIa [268].”
BackgroundInfluential
Metadata
- Authors
- Lima, M., Rudd, T., & Yates, E.
- Affiliations
- University of Liverpool (GB)
- Corresponding author
- Lima, Marcelo
- Rudd, Timothy
- Yates, Edwin
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2017-05-06
- Volume
- 22
- Issue
- 5
- Pages
- 749
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC6154012
- OpenAlex
- W2610898931
- Cited by
- 89
- References
- 102
- Citations by year
- 2026: 10 · 2025: 8 · 2024: 6 · 2023: 10 · 2022: 8 · 2021: 18 · 2020: 9 · 2019: 8 · 2018: 10 · 2017: 2
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Keele Research Repository (Keele University) (submittedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Life Sciences › Agricultural and Biological Sciences › Food Science › Polysaccharides Composition and Applications
- Physical Sciences › Materials Science › Surfaces, Coatings and Films › Polymer Surface Interaction Studies
- Keywords
- heparin, glycosaminoglycans, low molecular weight heparin, chondroitin sulfate, heparan sulfate, hyaluronic acid, anticoagulants, thrombosis, neurodegenerative diseases, protein binding, biotechnology applications
- MeSH terms
- Anticoagulants, Biotechnology, Glycosaminoglycans, Humans, Neoplasms, Thrombosis, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New Applications of Heparin and Other Glycosaminoglycans. https://app.cochat.ai/papers/10.3390/molecules22050749
- The paper
- Lima, M., Rudd, T., & Yates, E. (2017). New Applications of Heparin and Other Glycosaminoglycans. Molecules. https://doi.org/10.3390/molecules22050749
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.